Explore how scientists detect p53 proteins and antibodies in breast cancer patients using innovative immo-PCR technology for improved diagnosis and monitoring.
Discover how elacestrant, the first oral SERD approved for ER-positive, HER2-negative breast cancer with ESR1 mutations, is transforming treatment paradigms.
Discover how KLK4, a kallikrein-related peptidase, is transforming breast cancer diagnosis through its unique molecular signature and association with tumor aggression.
Exploring the unexpected role of prostate-specific antigen (PSA) as a potential diagnostic marker for breast cancer in women.
Exploring how biogenic silver nanoparticles from plants like Alternanthera sessilis precisely target breast cancer cells through apoptosis while sparing healthy tissue.
Discover how red blood cell membrane-coated nanoparticles are transforming triple-negative breast cancer imaging through advanced bioengineering techniques.